Aims: The EuroHeart Failure Survey Questionnaire (EHFSQ-1) has 39 questions on symptoms and quality of life (QoL); many items are related. We sought to identify underlying clusters amongst EHFSQ-1 questions, construct an overall "QoL score" and investigate its relationship to a single question asking patients to self-rate QoL.
Introduction
The goals of treating heart failure are to maintain or improve the quality of life by managing symptoms and reducing morbidity and disability and to prolong useful life.
Ultimately, improving the "patient journey" [1] or quality-adjusted life-years is the objective of both patients and their doctors. However, most clinical trials of heart failure focus on morbidity and mortality rather than on quality of life (QoL), which is usually measured infrequently during the course of the trial, if at all. This partly reflects a lack of confidence amongst both trialists and regulators about the validity of tools used to assess QoL and partly the perceived burden on both patients and investigators of completing existing QoL questionnaires repetitively. However, QoL questionnaires are asking two distinct questions; firstly "what is this patient"s QoL?" and secondly, "if impaired, "why"?". However, in a clinical trial the first question may be of greater importance. The second may give insights into how an intervention has changed QoL but with few exceptions [2] , this is never reported in trials. This issue could be addressed if investigators and regulators were willing to accept that the patient is the best judge of their QoL which could reduce the complexity of assessment of QoL to a single question that could be asked at every visit. This would permit the calculation of average QoL throughout the study as well as an assessment of the impact of morbid events on QoL. Trying to measure QoL using questionnaires is not straightforward. Inevitably, questionnaires concentrate on symptoms thought to be important by clinicians, but not necessarily patients, and include a large number of questions that are often highly related. Factor analysis (FA) [3, 4] reduces complex information by identifying latent structures in the data and extracting highly correlated sets of symptoms as "symptom clusters". Each symptom cluster can be scored and used for further analysis [5, 6] .
The aim of the present study was to identify symptom clusters in the EuroHeart Failure Survey Questionnaire used in the first survey (EHFSQ-1), to construct an overall "QoL score" from them and then to relate this score to patient self-reported QoL using single questions [7, 8] using data acquired routinely as part of a clinical heart failure service.
Methods
Patients referred to a community heart failure clinic (Kingston-upon-Hull, UK) for the assessment of heart failure symptoms were invited to participate. Patients underwent clinical examination, including demographic measurements, symptoms and signs, electrocardiograms, echocardiography and routine haematology and biochemical investigations. The questionnaire was designed by a group of experts to obtain data on symptom severity and quality of life in the first EuroHeart Failure survey. It has not, as far as we are aware, been subjected to detailed methodological validation.
Patients were sent the EuroHeart Failure Survey Questionnaire (EHFSQ-1), which comprises 39 questions (Table 2.1 and 2.2), in the post prior to attending the clinic.
No restriction was placed on seeking the advice and opinion of friends and relatives.
The first 37 questions (1-37) ask about specific symptoms. The response to each question could be: no, very little, a little, some, a lot, very much, unknown and was coded from 1 to 6; unknown was coded as 7 and was excluded in this study. The following four questions (18) (19) (20) (21) were very often left unanswered: inability to work due to your health; side effects that you think might be due to your treatment; difficulties with sexual function; and cost of medicines or medical care. They were excluded for the purposes of this analysis. The final two questions (38-39) ask about general health, and overall quality of life. Each could be answered: very good, good, quite good, average, quite poor, poor, very poor and unknown. The responses to both questions were coded from 1 to 7; unknown was coded as 8 and was excluded in the study All patients provided written informed consent for their data to be used and the study was carried out in accordance with the Helsinki Declaration II and the European Standards for Good Clinical Practice. Ethical approval was granted by the Hull and East Yorkshire Local Research Ethics Committee.
Patients were enrolled at first assessment in an out-patient clinic and all had a history suspicious of heart failure or concerns about important cardiac dysfunction. In the context of the sort of patients referred, heart failure was defined as being present if the left ventricular ejection fraction (LVEF) was less than 40% (heart failure with reduced ejection fraction; HFrEF) or, if LVEF was ≥ 40%, by an NT-proBNP >400ng/L (heart failure with normal ejection fraction; HFnEF). Patients who had both LVEF >40% and NT-proBNP <400ng/L were considered not to have heart failure for the purposes of this analysis, although other thresholds and criteria were considered.
Statistical analysis
Continuous variables are expressed as a median with inter quartile range; and categorical variables are given as percentages. Differences between the groups were examined using independent t-test or Mann-Whitney U test and chi-square tests for continuous and categorical variables respectively. Pearson"s correlation coefficient and Spearman"s correlation coefficient with scatter plots were used to assess the correlations or relationships between two variables depending on the distribution of the data.
Exploratory factor analysis (FA) was performed using principal component analysis (PCA). PCA is a data reduction technique which transforms a number of correlated variables into a smaller number of uncorrelated variables termed principal components (that is, linear combinations of the original variables) which explain a large proportion of the original sample variance. The 4 questions 18-21 mentioned above were not included in the analysis due to too many missing values and general overall QoL and overall health were not included. The remaining 33 questions were considered in the analysis.
To identify QoL symptom clusters, only principal components with initial eigenvalues >1 were extracted and an orthogonal factor rotation with Varimax method [9] applied.
The symptom clusters were labelled according to the characteristics of the original variables. Variables with a factor loading >0.4 were considered to be an important component of an underlying symptom cluster (Factor loading is a correlation between a variable and a factor. The higher the load the more relevant in defining the factor.).
Symptom cluster scores were calculated based on the Anderson-Rubin method [10] for further analysis. The sampling adequacy was checked by the Kaiser-Meyer-Olkin (KMO) test [11] . The 10-fold cross-validation was used to assess the stability of the analysis and Cronbach's alpha [12] was used for testing the reliability of questions on each symptom cluster.
Overall QoL scores were derived using either (1) the raw summary scores (ranging potentially from 31 (very good health) to 186 (terrible health)); or (2) the summary factor scores derived by the sum of each symptom cluster score, ranging from -5 to 10 in this dataset (a big number is associated with a bad health).
Statistical analysis was carried out using SPSS 17 software package. The two-tailed level of statistical significance was set at p<0.05.
Results

Baseline characteristics
Of 1,031 patients, 657 (64%) were men and the median age was 71 years (IQR: 63-77), 626 had HF (377 with HFrEF and 249 with HFnEF) and 405 did not fulfil the criteria for HF ( Table 1) . As expected, patients with HF had more severe symptoms, more cardiovascular problems, poorer renal function and substantially higher plasma concentrations of NT-proBNP despite receiving more loop diuretics, ACE inhibitors, beta blockers and spironolactone. Patients with HFnEF were older, more often women and had more atrial fibrillation and diabetes. BMI was greater in patients without heart failure but the rate of reported COPD was similar in each group.
The distributions of the responses of QoL questions for patients with HFrEF, HFnEF or No HF are shown in Table 2 . This showed a broadly similar pattern in patients with different heart failure phenotypes. There was also an extensive overlap in symptomatology between patients who were considered to have or not have heart failure. For instance, 15.7% of patients with HFrEF reported ankle swelling in the worst two ranks, compared to 22.8% of those with HFnEF and 17.5% of those without heart failure. Reports of severe breathlessness at rest were uncommon in this out-patient population and rare in patients without heart failure. For breathlessness during daily activity, 34.7% of patients with HFrEF reported scores in the worst two ranks, compared to 37.0% of those with HFnEF and 21.3% of those without heart failure. Fatigue during daily activity was reported in the worst two ranks in 26.8%, 27.7% and 16.3% of the above groups, respectively. Patients scoring chest pain in the worst two ranks were similar across diagnostic groups but patients without heart failure complained more of troublesome cough. The medians (IQR) of the summary 
Patterns of QoL
In the initial factor analysis 33 questions were considered. However, indigestion and SoA variables were removed from final FA because of small values of the communalities (<0.35) (the communality is the proportion of variation in the variable explained by all the symptom clusters). There were seven underlying QoL symptom clusters extracted from the 31 variables explained 65% of total variance. Factor loadings >0.4 were shown and important factor loadings >=0.7 were bolded ( Table 3 ).
The KMO test measuring the sampling adequacy was 0.929; values >0.5 indicate that the sample size is appropriate for FA. Bartlett"s test of sphericity showed that the correlations between items were sufficiently large for PCA (chi-square=10273, df = 465 and p<0.001). Cronbach's alpha showed a range of scores from 0.62 to 0.89 and five of seven scores had values >0.7, which indicates that the questionnaire has satisfactory internal reliability [13, 14] .
The following seven symptom clusters were extracted in patients with HF (Table 3 ):
1. The first cluster called "Breathlessness" accounted for 15% of the total variance in QoL. The cluster Breathlessness was highly related to: inability to do normal daily activities with the factor loading 0.78, fatigue on daily activities (0.76), breathless limiting normal daily activities (0.75) and reduced ability to pursue hobbies (0.73).
That is the cluster was mainly loaded by these questions.
2. The second cluster called "Psychological distress" including stress, depression and anxiety accounted for 13% of the total variance.
3. "Sleep quality" including insomnia, waking and lack of refreshing sleep accounted for 9% of the total variance.
4. "Frailty" included questions relating to making you stay in hospital, eating less food, finding going places away from home difficult and the need for stays in hospital accounted for 8% of the total variance. 6. "Respiratory symptoms" (cough, wheeze and breathless at night) accounted for 6% of the total variance.
7. "Chest pain" (chest pain at rest, chest pain at daily activity) were also extracted accounted for 6% of the total variance.
A 10-fold cross-validation for patients with HF was used and revealed the stability of the analysis (result was not shown. It can be found from on-line supplement).
Amongst patients who did not have heart failure, an 8 th symptom cluster, "falls", was identified, with the 8 clusters accounting for 66% of total variance (see Table 3 ).
Muscle aches and indigestion were not included in the final analysis due to small values of the communalities. The KMO test (0.919) for this group shows that the sample size was adequate. The components and the order in which they entered the symptom clusters, was slightly different from the patients with heart failure: patients with HF had clearer and more specific patterns than those without HF.
Relationships between single symptom scores and general overall QoL and overall health
There was a strong positive correlation between the summary QoL and the summary symptom cluster scores for both patients with and without HF (Pearson"s correlation coefficient: r = 0.964/0.954 respectively with p<0.001, Figure 1 and Table 4 .1). There was a strong relationship between two individual questions on "overall health" and "overall QoL" (Spearman"s correlation coefficient: r´ = 0.730/0.759 for patients with/without HF respectively, p<0.001). There were also strong relationships between overall health/overall QoL with the summary score and the summary symptom cluster score (r´= (0.661, 0.614) / (0.658, 0.602) respectively with p<0.001 for HF patients;
and r´= (0.667, 0.678) / (0.642, 0.654) respectively with p<0.001 for no HF patients).
Only the first symptom cluster ("Breathlessness") was highly related to the single questions on "overall QoL" and "overall health" (r´=0.50 and 0.47 respectively, p<0.001 for all; Table 4 .2) in patients with HF.
Relationships between QoL scores with NYHA class and NT-proBNP
On average, patients without heart failure had lower summary scores, and lower scores in response to single questions on overall QoL and overall health scores than patients with heart failure represented as NYHA class II/III/IV. QoL scores increased 
Discussion
This analysis suggests that when the main question of interest is simply "what is the patient"s quality of life", then asking the patients to rate it directly using a single question may be sufficient or perhaps superior to asking a series of related questions that skirt the issue, as is the case with QoL questionnaires. Use of a single question to assess QoL could greatly increase the acquisition of QoL data in clinical trials. Rather than being measured at infrequent intervals or not at all, it could become a standard part of every assessment. QoL is unlikely to be stable over long-periods of time in patients with heart failure. It will decline with progression of heart failure or due to intercurrent illness and, hopefully, improve with treatment. Acquiring more frequent information allows the relationship between events and interventions to be explored more effectively. However, a single question may not be the optimal method of assessing QoL in a clinical trial when used alone. A mixed approach, with frequent use of a single-question supported periodically by more detailed QoL questionnaires would provide a high density of information about QoL combined with insights about why it might be imperfect. Further research is required to identify whether the single question approach we used is the optimal method of patient self-rating or whether other approaches such as visual analogue scales might be better.
The EHFSQ-1 was designed as a tool to capture data on symptoms of heart failure and common associated co-morbidities as well as more general aspects of living that affecting their QoL. Whether differences would be observed if the questions were asked outside of a healthcare context is unclear and uncertain. Nonetheless, the breathlessness symptom cluster score was strongly related to the single questions on overall health and overall QoL. Indeed, if these questions were added to the factor analysis, they were both incorporated into the breathlessness symptom cluster.
Comparison of patients with and without heart failure shows substantial differences in clinical characteristics including age, and co-morbidities as well as cardiac dysfunction. There are also differences in symptomatology but these are relatively subtle, supporting the notion that diagnosis of heart failure by symptoms alone is unreliable. About 80% of patients with heart failure reported that they developed some degree of breathlessness during normal daily activity, although this was marked in only one third of patients. However, two-thirds of patients without heart failure reported some breathlessness during daily activity and this was marked in more than 20%. Many of these patients had other problems such as obesity, angina, COPD or musculo-skeletal problems that could provoke breathlessness and impair QoL. It was also possible that some patients were misclassified; the cut-off for NT-proBNP may have been too high or diuretics could have concealed features of heart failure. Indeed, patients who were not taking diuretics or who had an NT-proBNP <125ng/L had better QoL scores. Interestingly, patients taking diuretics that had no other criteria for heart failure had similar QoL scores to patients with mild to moderate heart failure, suggesting that the diagnostic criteria for heart failure may have been too strict. There are very few reports on the distribution of symptom scores in questionnaires in consecutive patients with heart failure referred for diagnosis and care to a heart failure clinic and none on patients with suspected heart failure where the diagnosis was refuted. The EHFSQ-1 score was much higher (worse) in patients where the diagnosis of heart failure was confirmed and in patients who were in a more severe NYHA class. QoL score appeared to be related to NT-proBNP, a marker of the severity of cardiac dysfunction and prognosis. Our NT-proBNP threshold for the diagnosis of heart failure was based on an interpretation of the 2008 guidelines on heart failure of the European Society of Cardiology [20] . Guidelines have since revised the threshold downward and it is likely that some patients with HFnEF but well-controlled congestion will have "contaminated" the no heart failure group. This sort of problem cannot be resolved until a clear and robust definition of HFnEF is agreed. However, patients with HFnEF and an NT-proBNP <400ng/L have a much better prognosis than those with higher levels. Moreover, there is, as yet, no specific disease-modifying therapy for HFnEF and therefore subtle differences in the definition will not alter management decisions.
We used principal component analysis (PCA) to extract factors. There is a basic difference between factor analysis and PCA. Factor analysis is based on a statistical model. It seeks the smallest number of unobserved latent variables (or potential factors) that explain the original data. On the other hand, PCA is a transformation, which reduces a relatively large number of variables into a small number of "principal" components that explain a large proportion of the total sample variance of the original variables 5 . However, Rietveld and Van Hout pointed out that "the difference between factor analysis and PCA decreased when the number of variables and the magnitudes of the factor loadings increased [21] " and the results of PCA are little different from those derived from factor analysis [22] . Exploratory factor analysis has the advantages of analysing the structure of data especially when correlations between variables are reasonably high and there are a large number of variables. Although the method overcomes many of the problems related to analysis of a high number of variables many of which are related.
There are some limitations. In EHFSQ-1, four questions related to work, drug side effects, costs of care and sexual activities were excluded due to a large number of missing values, perhaps reflecting the age of this population and free access to health care provided by the NHS in the UK. Clearly, the EHSQ-1 should be tested for reproducibility, sensitivity to change, assessed in additional datasets and healthcare settings and compared to other QoL tools. Several such projects are underway.
However, 10-fold cross-validation has been used to assess the stability of the analysis and Cronbach's alpha method has been used for testing the internal consistency of questions scores.
In conclusion, for patients with suspected HF, if the aim is to measure QoL it may be best just ask the patient a simple question such as "how do you rate your overall health?" or "how do you rate your overall QoL? Only if it is important to know why a patient"s QoL is less than ideal is it necessary to ask further questions. When QoL is being used as an outcome measure then it is usual only to report a summary score or a summary symptom cluster score and all the underlying detailed information usually goes unreported. Thus, a single question about QoL or patient well-being may suffice for most purposes. The greater number and frequency of questions asked the less likely they are to be completed. Less is more.
Supplementary material
Supplementary material is available at International journal of cardiology online.
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Prof Supplements: Figure 1 : Loading of first factor ("breathlessness") for each dataset in 10-fold cross-validation for patients in heart failure. It shows a consistent pattern over all the 10 datasets. Interpretation of the values (the 33 QoL questions) on the x-axis is provided in Table 2 .
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